Table 1.
Clinical characteristics of the study patients.
| n | % | |
|---|---|---|
| Sex | ||
| Male | 37 | 50.7 |
| Female | 36 | 49.3 |
| Mean age at the FL diagnosis (range), years | 65.8 ± 11.6 (38–90) | |
| Gastrointestinal involvement | ||
| Esophagus | 0 | 0.0 |
| Stomach | 1 | 1.4 |
| Duodenum | 69 | 94.5 |
| Jejunum | 11 | 15.1 |
| Ileum | 4 | 5.5 |
| Cecum | 0 | 0.0 |
| Colon | 1 | 1.4 |
| Rectum | 2 | 2.7 |
| Stage | ||
| Lugano I | 72 | 98.6 |
| Lugano II1 | 1 | 1.4 |
| Endoscopy examinations performed | ||
| Esophagogastroduodenoscopy | 73 | 100 |
| Colonoscopy | 57 | 78.1 |
| Video capsule enteroscopy | 24 | 32.9 |
| Balloon-assisted enteroscopy | 7 | 9.6 |
| Mean follow-up period (range), years | 8.3 ± 4.3 (0.3–22.8) | |
| Median follow-up period, years | 8.1 | |
| Outcome at the last visit | ||
| Alive with lymphoma | 46 | 63.0 |
| Alive, NED without treatment | 12 | 16.4 |
| Alive, NED with treatment | 5 | 6.8 |
| Alive with lymphoma after treatment | 1 | 1.4 |
| Dead by other causes than lymphoma | 9 | 12.3 |
FL follicular lymphoma; NED no evidence of disease.